CompletedPhase 2

Konjac-Mannan Improves Glycemia and Other Risk Factors for CHD in T2DM

11 participantsStarted 1991-01

Plain-language summary

To examine whether Konjac-mannan fiber improves metabolic control measured by glycemia, lipidemia, and blood pressure in individuals with type-2 diabetes.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * hyperlipidemia controlled by medication * hypertension controlled by medication * type 2 diabetes controlled by medication * minimum 3 years since onset of all three conditions * sedentary lifestyle Exclusion Criteria: * regular smoking * regular alcohol consumption * family history of premature coronary heart disease * hypothyroidism * renal, hepatic or gastrointestinal disease

What they're measuring

change in total:HDL cholesterol

Timeframe: change from baseline at week 3, relative to control

change in fructosamine

Timeframe: change from baseline at week 3, relative to control

change in systolic blood pressure

Timeframe: change from baseline at week 3, relative to control

Trial details

NCT IDNCT03741660

SponsorUnity Health Toronto

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion1992-06

View on ClinicalTrials.gov More Type2 Diabetes trials